The Lausanne University Hospital, in Lausanne, is one of the five university hospitals in Switzerland. The Lausanne University Hospital is linked to the Faculty of Biology and Medicine of the University of Lausanne. The CHUV's medical services benefit over 45,000 patients a year.

There are 1,568 beds in University Hospital of Lausanne.

During the past decade, University Hospital of Lausanne conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 5 clinical trials were completed, i.e. on average, 5.2% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 5 clinical trials were completed. i.e. 10.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of Lausanne" #1 sponsor was "University of Lausanne Hospitals" with 33 trials, followed by "Centre Hospitalier Universitaire Vaudois" with 11 trials sponsored, "University of Lausanne" with 7 trials sponsored, "University Hospital, Basel, Switzerland" with 6 trials sponsored and "University Hospital, Geneva" with 6 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Lausanne" #1 collaborator was "University of Lausanne Hospitals" with 20 trials as a collaborator, "University Hospital, Geneva" with 10 trials as a collaborator, "University of Bern" with 7 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 6 trials as a collaborator and "Swiss National Science Foundation" with 6 trials as a collaborator. Other collaborators include 214 different institutions and companies that were collaborators in the rest 189 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Lausanne" are "Coronary Artery Disease" (4 trials), "Pulmonary Embolism" (4 trials), "Analgesia" (3 trials), "Multiple Sclerosis" (3 trials) and "Stroke" (3 trials). Many other conditions were trialed in "University Hospital of Lausanne" in a lesser frequency.

Most popular intervention types in "University Hospital of Lausanne" are "Drug" (27 trials), "Other" (25 trials), "Device" (19 trials), "Procedure" (16 trials) and "Behavioral" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Interscalene brachial plexus block" (2 trials), "Nivolumab" (2 trials), ""Fixed long" antibiotic course of 14 days" (1 trials) and ""Fixed short" antibiotic course of 7 days" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Lausanne" are 129 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital of Lausanne". 2 are not yet recruiting, 34 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in University Hospital of Lausanne, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Lausanne, 8 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 52 trials that are defined as “Not Applicable".

University Hospital of Lausanne has several departments that took part in Clinical trials: "Intensive care and burn unit, University hospital of Lausanne" - 5 trials